Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

about

High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.American BRCA Outcomes and Utilization of Testing (ABOUT) study: a pragmatic research model that incorporates personalized medicine/patient-centered outcomes in a real world setting.

P2860

Q34240064-C3329CDD-2D1C-487F-B4A7-FE122415BD3D Q38395022-D1B37B1E-03EC-4C91-8A45-29D8AD79C7FC

P2860

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

Item

http://www.wikidata.org/entity/Q35684391

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

@ast

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

@en

type

Item

label

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

@ast

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

@en

prefLabel

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

@ast

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

@en

P1476

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

@en

P2093

Kathleen M Erb

http://www.w3.org/2001/XMLSchema#string

Megan L Marshall

http://www.w3.org/2001/XMLSchema#string

Randal L Croshaw

http://www.w3.org/2001/XMLSchema#string

Tesha L Williams

http://www.w3.org/2001/XMLSchema#string

Thomas B Julian

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Meta-analysis of BRCA1 and BRCA2 penetrance

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

Linkage of early-onset familial breast cancer to chromosome 17q21

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Association of BRCA1 with Rad51 in mitotic and meiotic cells

Hallmarks of 'BRCAness' in sporadic cancers

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

P304

481563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4061/2011/481563

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221796393

http://www.w3.org/2001/XMLSchema#string

P698

22295226

http://www.w3.org/2001/XMLSchema#string

P932

3262559

http://www.w3.org/2001/XMLSchema#string

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

about

P2860

P2860

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932